In our research, PANC1 and BxPC3 recruited more coro1a: GFP+ innate immune cells to the TME compared to AsPC1 cells, and the co-localization of coro1a: GFP+ cells with the tumor cells was increased from 1 dpi to 4 dpi by three-fold for PANC1 and BxPC3. The gene discussed is CORO1A; the disease is neoplasm.